#Japan #Hearing Loss #Chiyoda #Pitakiko #Inner Ear

Introduction

On July 15, 2026, Dr. Series Inc., based in Chiyoda, Tokyo, is set to release a groundbreaking product: Pitakiko Inner Ear Tablets Clear. Recognized as a second-class pharmaceutical, this medication is focused on alleviating ailments related to hearing difficulties, such as hearing loss and tinnitus, particularly for those experiencing physical frailty. The product will be available for purchase through the official online shop at Dr. Series.

What is Pitakiko Inner Ear Tablets Clear?

Pitakiko Inner Ear Tablets Clear is designed specifically to address various symptoms associated with physical weakness, primarily:

• - Hearing loss
• - Tinnitus
• - Dizziness

Incorporating extensive research and clinical insights, the medication promises to deliver effective relief, particularly to seniors and families confronting the challenges of hearing issues. It serves as a reliable solution backed by regulatory approval.

A Solution to Hearing Problems

Hearing challenges like difficulty in understanding sounds and persistent ringing in the ears can transform from mere annoyances into significant obstacles affecting daily life. These issues may lead to increased stress, anxiety, and deteriorating communication with loved ones. Often, individuals resign themselves to these conditions, believing they are merely a product of aging.

Dr. Series holds a commitment to enhancing the quality of life through trustworthy product innovation. With this vision, we developed Pitakiko Inner Ear Tablets Clear, delivering proven efficacy to those grappling with hearing difficulties and enabling them to reclaim a fulfilling daily life.

Key Features of Pitakiko Inner Ear Tablets Clear

1. Effective Relief for Hearing Loss and Tinnitus
The tablets come with the assurance of efficacy approved for conditions such as tinnitus, hearing loss, and dizziness related to physical weakness.

2. Collaboration with a Renowned Pharmaceutical Company
A partnership between Dr. Series and a 69-year-old veteran pharmaceutical company culminates in this product. Expertise in healthcare product development, combined with rigorous quality assurance measures, assures customers of a high-quality solution.

3. Easy-to-Take Tablet Form
Accommodating the daily routines of users, the product is formulated as a small tablet that can be smoothly swallowed. Users are encouraged to follow a simple regimen of taking the tablets three times daily, which integrates seamlessly into their lifestyle. For specific dosing details, please refer to the product page or accompanying literature.

Product Overview

• - Product Name: Pitakiko Inner Ear Tablets Clear
• - Content: 225 tablets (sufficient for 15 days)
• - Indications: Effective for symptoms like tinnitus, hearing loss, and dizziness in those with physical weakness.
• - Dosage: Adults (15 years and older) should take 5 tablets, three times a day, before or between meals. Not suitable for individuals under 15 years.
• - Precautions: It is crucial for certain individuals, such as those under medical treatment or with specific health conditions, to consult with a healthcare professional before use. Potential side effects such as nausea or abdominal discomfort should prompt termination of use and consultation. If symptoms persist after a month, further medical advice should be sought.

When Will It Be Available?

Pitakiko Inner Ear Tablets Clear will officially launch on July 15, 2026. Customers can conveniently order them through the official online shop here.

Frequently Asked Questions

Q: What symptoms does Pitakiko Inner Ear Tablets Clear address?
A: This medication has been approved for conditions primarily affecting those with physical weakness, including tinnitus, hearing loss, and dizziness.

Q: How should the tablets be taken?
A: Adults aged 15 and above can take 5 tablets three times a day, and ingestion should occur before or between meals. It is not intended for children under 15.

Q: What is the pricing?
A: The 225 tablet (15-day supply) pack is priced at 6,225 JPY (including tax) on the official website.

Q: Where can I purchase it?
A: The product will be available at the Dr. Series official online shop here.

Important Note: This product is classified as a second-class pharmaceutical. It is imperative to read the accompanying documentation carefully and adhere to the recommended usage guidelines. If any health concerns arise, please consult a healthcare professional.

Company Overview

• - Company Name: Dr. Series Inc.
• - Location: 4-5-20 Koji-cho, Chiyoda, Tokyo, KS Building, 8F
• - CEO: Yotaro Iwai
• - Established: February 2019
• - Website: Dr. Series
• - Business Focus: Planning, development, and sales of pharmaceuticals and healthcare products.

For more information or inquiries, please contact Dr. Series Inc.
Public Relations:
TEL: 0120-520-067
MAIL: [email protected]

This product is classified as a second-class pharmaceutical. Always read the package insert carefully and use according to the guidelines provided. Consult a healthcare professional for any concerning symptoms.